These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15810901)

  • 1. The clinical syndrome of Alzheimer's disease: aspects particularly relevant to clinical trials.
    Mohs RC
    Genes Brain Behav; 2005 Apr; 4(3):129-33. PubMed ID: 15810901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
    Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease.
    Cummings J; Zhong K
    Clin Pharmacol Ther; 2015 Nov; 98(5):483-5. PubMed ID: 26206713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological assessment in the diagnosis of Alzheimer's disease.
    Baldwin S; Farias ST
    Curr Protoc Neurosci; 2009 Oct; Chapter 10():Unit10.3. PubMed ID: 19802814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of neuropsychiatric symptoms in mild cognitive impairment.
    Monastero R; Mangialasche F; Camarda C; Ercolani S; Camarda R
    J Alzheimers Dis; 2009; 18(1):11-30. PubMed ID: 19542627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denial of memory deficit in Alzheimer's disease.
    Sevush S; Leve N
    Am J Psychiatry; 1993 May; 150(5):748-51. PubMed ID: 8480820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen replacement therapy: effects on the cognitive functioning and clinical course of women with Alzheimer's disease.
    Levine AJ; Battista M
    Arch Clin Neuropsychol; 2004 Sep; 19(6):769-78. PubMed ID: 15288330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological predictors of dependency in patients with Alzheimer disease.
    Sarazin M; Stern Y; Berr C; Riba A; Albert M; Brandt J; Dubois B
    Neurology; 2005 Mar; 64(6):1027-31. PubMed ID: 15781821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unawareness of memory impairment and behavioral abnormalities in patients with Alzheimer's disease: relation to professional health care burden.
    Al-Aloucy MJ; Cotteret R; Thomas P; Volteau M; Benmaou I; Dalla Barba G
    J Nutr Health Aging; 2011 May; 15(5):356-60. PubMed ID: 21528161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of treatment-associated changes in behavior and cholinergic therapy of neuropsychiatric symptoms in Alzheimer's disease.
    Cummings JL; Masterman DL
    J Clin Psychiatry; 1998; 59 Suppl 13():23-30. PubMed ID: 9771827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clusters of cognitive and behavioral disorders clearly distinguish primary progressive aphasia from frontal lobe dementia, and Alzheimer's disease.
    Marra C; Quaranta D; Zinno M; Misciagna S; Bizzarro A; Masullo C; Daniele A; Gainotti G
    Dement Geriatr Cogn Disord; 2007; 24(5):317-26. PubMed ID: 17851236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do subgroups of patients with Alzheimer's disease exhibit asymmetric deficits on memory tests?
    Demadura T; Delis DC; Jacobson M; Salmon D
    J Clin Exp Neuropsychol; 2001 Apr; 23(2):164-71. PubMed ID: 11309670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavioural and psychological symptoms in dementia in Alzheimer's disease].
    Benoit M; Robert P
    Rev Prat; 2005 Nov; 55(17):1895-901. PubMed ID: 16396230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
    Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
    Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key lessons learned from short-term treatment trials of cholinesterase inhibitors for amnestic MCI.
    Salloway S; Correia S; Richardson S
    Int Psychogeriatr; 2008 Feb; 20(1):40-6. PubMed ID: 17597552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory problems in dementia: adaptation and coping strategies and psychosocial treatments.
    Dröes RM; van der Roest HG; van Mierlo L; Meiland FJ
    Expert Rev Neurother; 2011 Dec; 11(12):1769-81; quiz 1782. PubMed ID: 22091600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease.
    Ito T; Meguro K; Akanuma K; Meguro M; Lee E; Kasuya M; Ishii H; Mori E
    J Clin Neurosci; 2007 Sep; 14(9):850-5. PubMed ID: 17587584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological study of the amerliorative effects of Yokukansan on memory impairment and the behavioral and psychological symptoms of dementia in AD models].
    Kubota K; Nogami A; Takasaki K; Katsurabayashi S; Mishima K; Fujiwara M; Iwasaki K
    Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):110-4. PubMed ID: 24614632
    [No Abstract]   [Full Text] [Related]  

  • 19. Cognitive subdomain responses to galantamine in Alzheimer's disease.
    Song J; Ahn IS; Kang HS; Myung W; Lee Y; Woo SY; Ku HM; Hwang TY; Carroll BJ; Kim DK
    J Nerv Ment Dis; 2014 Mar; 202(3):253-9. PubMed ID: 24566512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive-behavioral profiles of neurodegenerative dementias: beyond Alzheimer's disease.
    Levy JA; Chelune GJ
    J Geriatr Psychiatry Neurol; 2007 Dec; 20(4):227-38. PubMed ID: 18004009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.